Scynexis (SCYX) Common Equity (2013 - 2026)
Scynexis' Common Equity came in at $66.93 million for Q2 2026, up 50.5% from $44.47 million a year earlier and up 62.0% from the prior quarter.
Powered by 
Analysis
Scynexis (SCYX) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Scynexis' Common Equity was $49.38 million, down 10.4% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
- Going back by year, Common Equity was $55.08 million in FY2024 (-24.5%), $72.96 million in FY2023, $3.23 million in FY2022 (-92.2%) and $41.26 million in FY2021 (+81.3%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q1 2024.
- Year-over-year, Common Equity increased in 1 of the last eight quarters, with an average decline of 16.9%.
- The fastest year-over-year change in Common Equity over five years came in Q3 2023 (growth of 434.6%), and the weakest in Q4 2022 (a decline of 92.2%).
- Business Quant data shows SCYX's Common Equity at $41.31 million (Q1 2026), $49.38 million (Q4 2025) and $36.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Scynexis | 45.97 Mn | -25.13 Mn | - | 66.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.93 Mn |
| Mar 31, 2026 | 41.31 Mn |
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 44.47 Mn |
| Mar 31, 2025 | 50.53 Mn |
| Dec 31, 2024 | 55.08 Mn |
| Sep 30, 2024 | 58.53 Mn |
| Jun 30, 2024 | 60.41 Mn |
| Mar 31, 2024 | 74.11 Mn |
| Dec 31, 2023 | 72.96 Mn |
| Sep 30, 2023 | 91.99 Mn |
| Jun 30, 2023 | 93.08 Mn |
| Mar 31, 2023 | -29.91 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 17.21 Mn |
| Jun 30, 2022 | 45.48 Mn |
| Mar 31, 2022 | 38.93 Mn |
| Dec 31, 2021 | 41.26 Mn |
| Sep 30, 2021 | 37.61 Mn |
API Access
Scynexis Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SCYX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SCYX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SCYX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();